The study of carbohydrate containing biomolecules and carbohydrates in the biological process such as cell-to-cell interaction, cell recognition, infection and inflammation, and the immune response is known as glycomics. The process mainly depends on the intricate glycan structures, which are present on interacting biomolecules. Glycan microarrays, carbohydrate chemistry, and high-throughput mass spectroscopy are the advanced technologies that assist in order to unfold the complexity resulting from this diversity.

Market Analysis and Insights: Global Glycobiology/Glycomics Market
In 2020, the global Glycobiology/Glycomics market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Glycobiology/Glycomics Scope and Market Size
The global Glycobiology/Glycomics market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Glycobiology/Glycomics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Eagents
Enzymes
Kits
Instruments

Segment by Application
Oncology
Diagnostics
Immunology
Drug Discovery and Development
Others

By Company
Thermo Fisher Scientific
Agilent Technologies
New England Biolabs
Waters Corp
Bruker Corp
Sigma-Aldrich Corp
Takara Bio
Prozyme
Danaher Corp
Shimadzu Corp

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE